• site map

• text size: A- | A+

• : . view text-only
• : . view graphic version

• Research Home
• Neurosciences
• Environmental Toxicology
• Cardiovascular Pharmacology
• Medicinal Chemistry
• Pharmocogenetics
• Cancer Research
• Centers and Facilities

Cancer Research

Mechanisms, preventative measures, therapeutic development, thoracic and CNS neoplasms, immune response and modulation in cancer, anticancer drug discovery, brain tumor development, glutamate-mediated neuropathology.

Erica L. Woodahl, Assistant Professor, Ph.D. (pharmaceutics), University of Washington, 2004.  Pharmacogenomics of drug transporters and drug-metabolizing enzymes in drug response, toxicity, and disease susceptibility.

Mark A. Pershouse, Associate Professor; Ph.D. (biomedical sciences), Texas-Houston Health Sciences Center, 1993. Molecular genetics of human cancer; genomic expression analysis for detection of toxic injury; cancer detection and diagnostics; role of SV40 virus in human cancers; bioinformatics, and mechanisms of asbestos toxicity.

Elizabeth A. Putnam, Associate Professor; Ph.D. (biomedical sciences), Texas-Houston Health Sciences Center, 1989. Gene-environment interactions in the development of disease, focusing on cancer and fibrotic disease development after asbestos exposure using both mouse models and human studies.

David M. Shepherd, Associate Professor; Ph.D. (environmental and molecular toxicology), Oregon State, 1999. Immunomodulation by nutraceuticals and dietary supplements with a special emphasis on chronic inflammatory diseases such as arthritis and asthma; mechanisms of immunotoxicity following exposure to environmental chemicals such as the halogenated aromatic hydrocarbons (e.g., TCDD and PCBs).

Howard D. Beall, Professor; Ph.D. (medicinal chemistry), Florida, 1991. Cardiovascular toxicology and environmental agents; anticancer drug discovery; cancer prevention.

Richard J. Bridges, Professor; Ph.D. (biochemistry), Cornell, 1984. Pharmacology and toxicology related to excitatory amino acid transporters, receptors and glutamate-mediated neuropathology.

J. Douglas Coffin, Professor; Ph.D. (anatomy and cell biology), SUNY Health Sciences Center at Syracuse, 1989. Genetic basis of mammalian growth and development and the function of growth factors in those processes.

Diana I. Lurie, Professor; Ph.D. (neuroscience), Pennsylvania, 1989. Development and regeneration of the nervous system. The effect of toxins such as lead on CNS development and the neural and glial response to injury.

Nicholas Natale, Professor; Ph.D. (organic chemistry), Drexel University, 1979. Isoxazoles in medicinal chemistry, especially applied towards potential anti-hypertensive anti-cancer and Alzheimer's therapeutics.